Beckman Coulter IO detects CD45-FITC/CD14-PE monoclonal antibodies - Taiwan Registration 26c29623b51894dfcb8ec96f5a2e2491

Access comprehensive regulatory information for Beckman Coulter IO detects CD45-FITC/CD14-PE monoclonal antibodies in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 26c29623b51894dfcb8ec96f5a2e2491 and manufactured by IMMUNOTECH SAS, A BECKMAN COULTER COMPANY. The authorized representative in Taiwan is BECKMAN COULTER TAIWAN INC., TAIWAN BRANCH (U.S.A.).

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.